NATALIE LAU: Open Payments
NPI 1497482137 · VERONA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,144 in 187 payments from 21 companies in 2025. Trend: 2023 $1,436 · 2024 $2,191 · 2025 $3,144
Food & beverage: $2,961Education: $183
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $465 |
| Janssen Biotech, Inc. | 14 | $399 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $282 |
| PFIZER INC. | 16 | $271 |
| Regeneron Healthcare Solutions, Inc. | 14 | $236 |
| UCB, Inc. | 7 | $213 |
| Galderma Laboratories, L.P. | 16 | $202 |
| Botanix SB Inc | 11 | $160 |
| Novartis Pharmaceuticals Corporation | 5 | $153 |
| LEO Pharma Inc. | 12 | $142 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, CIBINQO, Bimzelx, SOFDRA, OPZELURA, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
